1. HOWSON CP, KINNEY MV, MCDOUGALL L, et al. :Born too soon: preterm birth matters. Reprod Health 2013;10 Suppl 1:S1.
2. STOLL BJ, HANSEN NI, BELL EF, et al. :Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. Jama 2015;314:1039-51.
3. ROBERTS D, BROWN J, MEDLEY N, et al. :Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017;3:CD004454.
4. LIGGINS GC, HOWIE RN. :A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
5. MASSARO D, MASSARO GD. :Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am J Physiol 1986;251:R218- 24.
6. DEMPSEY EM. :What Should We Do about Low Blood Pressure in Preterm Infants. Neonatology 2017;111:402-07.
7. SECKL JR, HOLMES MC. :Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007;3:479-88.
8. KEMP MW, JOBE AH, USUDA H, et al. :Efficacy and safety of antenatal steroids. Am J Physiol Regul Integr Comp Physiol 2018;315:R825-R39.
9. JOBE AH, KEMP M, SCHMIDT A, et al. :Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatr Res 2020.
10. KUMAGAI Y, KEMP MW, YAEGASHI N, et al. :Contemporary Challenges and Developments: Antenatal Corticosteroid Therapy. Current Obstetrics and Gynecology Reports 2019;8:115-22.
11. JOBE AH, KEMP MW, KAMATH-RAYNE B, et al. :Antenatal corticosteroids for low and middle income countries. Semin Perinatol 2019;43:241-46.
12. OLADAPO OT, VOGEL JP, PIAGGIO G, et al. :Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries. N Engl J Med 2020.
13. JOBE AH, GOLDENBERG RL. :Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol 2018;219:62-74.
14. IKEGAMI M, JOBE AH, NEWNHAM J, et al. :Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997;156:178-84.
15. ASZTALOS EV, MURPHY KE, WILLAN AR, et al. :Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr 2013;167:1102-10.
16. STUTCHFIELD PR, WHITAKER R, GLIDDON AE, et al. :Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed 2013;98:F195-200.
17. ALEXANDER N, ROSENLÖCHER F, DETTENBORN L, et al. :Impact of Antenatal Glucocorticoid Therapy and Risk of Preterm Delivery on Intelligence in Term-Born Children. J Clin Endocrinol Metab 2016;101:581-9.
18. SAVOY C, FERRO MA, SCHMIDT LA, et al. :Prenatal betamethasone exposure and psychopathology risk in extremely low birth weight survivors in the third and fourth decades of life. Psychoneuroendocrinology 2016;74:278- 85.
19. RÄIKKÖNEN K, GISSLER M, KAJANTIE E. :Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. Jama 2020;323:1924-33.
20. ALEXANDER N, ROSENLOCHER F, STALDER T, et al. :Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term- born children. J Clin Endocrinol Metab 2012;97:3538-44.
21. DALZIEL SR, WALKER NK, PARAG V, et al. :Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. The Lancet 2005;365:1856-62.
22. CONSTANTINOF A, MOISIADIS VG, KOSTAKI A, et al. :Antenatal Glucocorticoid Exposure Results in Sex-Specific and Transgenerational Changes in Prefrontal Cortex Gene Transcription that Relate to Behavioural Outcomes. Sci Rep 2019;9:764.
23. BAL MP, DE VRIES WB, VAN DER LEIJ FR, et al. :Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: studies in 4-week-old prepubertal rats. Pediatr Res 2005;58:46-52.
24. DE VRIES WB. :Alterations in Adult Rat Heart after Neonatal Dexamethasone Therapy. Pediatric Research 2002;52:900-06.
25. DOYLE LW, FORD GW, DAVIS NM, et al. :Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clinical Science 2000;98:137-42.
26. NIXON PA, WASHBURN LK, MICHAEL O'SHEA T, et al. :Antenatal steroid exposure and heart rate variability in adolescents born with very low birth weight. Pediatr Res 2017;81:57-62.
27. MUANGMINGSUK S, INGRAM P, GUPTA MP, et al. :Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription. Molecular and Cellular Biochemistry 2000;209:165-73.
28. GAY MS, LI Y, XIONG F, et al. :Dexamethasone Treatment of Newborn Rats Decreases Cardiomyocyte Endowment in the Developing Heart through Epigenetic Modifications. PLoS One 2015;10:e0125033.
29. WHITEHURST RM, ZHANG M, BHATTACHARJEE A, et al. :Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca2+ current. Journal of Molecular and Cellular Cardiology 1999;31:1551-58.
30. REN R, OAKLEY RH, CRUZ-TOPETE D, et al. :Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology 2012;153:5346-60.
31. SEVERINOVA E, ALIKUNJU S, DENG W, et al. :Glucocorticoid Receptor- Binding and Transcriptome Signature in Cardiomyocytes. J Am Heart Assoc 2019;8:e011484.
32. ROMEJKO-WOLNIEWICZ E, TELIGA-CZAJKOWSKA J, CZAJKOWSKI K. :Antenatal steroids: can we optimize the dose? Curr Opin Obstet Gynecol 2014;26:77-82.
33. KEMP MW, SCHMIDT AF, JOBE AH. :Optimizing antenatal corticosteroid therapy. Semin Fetal Neonatal Med 2019;24:176-81.
34. SCHMIDT AF, KEMP MW, RITTENSCHOBER-BOHM J, et al. :Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep. Am J Obstet Gynecol 2018;218:132 e1-32 e9.
35. SCHMIDT AF, KANNAN PS, BRIDGES JP, et al. :Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques. Sci Rep 2019;9:9039.
36. KEMP MW, SAITO M, USUDA H, et al. :Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate. Am J Obstet Gynecol 2016;215:775 e1-75 e12.
37. KEMP MW, SAITO M, USUDA H, et al. :The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy. Am J Obstet Gynecol 2018;219:301 e1-01 e16.
38. KEMP MW, SAITO M, SCHMIDT AF, et al. :The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation. Am J Obstet Gynecol 2020;222:183 e1-83 e9.
39. HUANG DA W, SHERMAN BT, LEMPICKI RA. :Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
40. DERKS JB, GIUSSANI DA, JENKINS SL, et al. :A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 1997;499 ( Pt 1):217-26.
41. ERVIN MG, BERRY LM, IKEGAMI M, et al. :Single dose fetal betamethasone administration stabilizes postnatal glomerular filtration rate and alters endocrine function in premature lambs. Pediatr Res 1996;40:645-51.
42. OMAR SA, DECRISTOFARO JD, AGARWAL BI, et al. :Effects of prenatal steroids on water and sodium homeostasis in extremely low birth weight neonates. Pediatrics 1999;104:482-8.
43. EKIN A, GEZER C, SOLMAZ U, et al. :Effect of antenatal betamethasone administration on Doppler velocimetry of fetal and uteroplacental vessels: a prospective study. J Perinat Med 2016;44:243-8.
44. URBAN R, LEMANCEWICZ A, PRZEPIESC J, et al. :Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms. Eur J Obstet Gynecol Reprod Biol 2005;120:170-4.
45. WYRWOLL CS, NOBLE J, THOMSON A, et al. :Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess. Proc Natl Acad Sci U S A 2016;113:6265-70.
46. DERVISOGLU P, KOSECIK M, KUMBASAR S. :Effects of gestational and pregestational diabetes mellitus on the foetal heart: a cross-sectional study. J Obstet Gynaecol 2018;38:408-12.
47. HARADA K, RICE MJ, SHIOTA T, et al. :Gestational age- and growth-related alterations in fetal right and left ventricular diastolic filling patterns. Am J Cardiol 1997;79:173-7.
48. ROZMUS-WARCHOLINSKA W, WLOCH A, ACHARYA G, et al. :Reference values for variables of fetal cardiocirculatory dynamics at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2010;35:540-7.
49. CLIFTON VL, READ MA, LEITCH IM, et al. :Corticotropin-releasing hormone- induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate- mediated pathway. J Clin Endocrinol Metab 1995;80:2888-93.
50. AGNEW EJ, GARCIA-BURGOS A, RICHARDSON RV, et al. :Antenatal dexamethasone treatment transiently alters diastolic function in the mouse fetal heart. J Endocrinol 2019;241:279-92.
51. ROMERO R, ESPINOZA J, GONCALVES LF, et al. :Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2004;16:146-57.
52. CRISPI F, COMAS M, HERNANDEZ-ANDRADE E, et al. :Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction? Ultrasound Obstet Gynecol 2009;34:660-5.
53. HERNANDEZ-ANDRADE E, BENAVIDES-SERRALDE JA, CRUZ-MARTINEZ R, et al. :Evaluation of conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial performance index. Fetal Diagn Ther 2012;32:22-9.
54. LA MEAR NS, MACGILVRAY SS, MYERS TF. :Dexamethasone-induced myocardial hypertrophy in neonatal rats. Biol Neonate 1997;72:175-80.
55. LEE KN, LU X, NGUYEN C, et al. :Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice. J Mol Cell Cardiol 2017;108:194-202.
56. PERRINO C, NAGA PRASAD SV, MAO L, et al. :Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 2006;116:1547-60.
57. SHEN Z, ZHANG Z, WANG X, et al. :VEGFB-VEGFR1 ameliorates Ang II- induced cardiomyocyte hypertrophy through Ca(2+) -mediated PKG I pathway. J Cell Biochem 2018;119:1511-20.
58. CHAN LL, SÉBERT SP, HYATT MA, et al. :Effect of maternal nutrient restriction from early to midgestation on cardiac function and metabolism after adolescent-onset obesity. Am J Physiol Regul Integr Comp Physiol 2009;296:R1455-63.
59. LANGDOWN ML, HOLNESS MJ, SUGDEN MC. :Early growth retardation induced by excessive exposure to glucocorticoids in utero selectively increases cardiac GLUT1 protein expression and Akt/protein kinase B activity in adulthood. J Endocrinol 2001;169:11-22.
60. IEMITSU M, MIYAUCHI T, MAEDA S, et al. :Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res 2003;26:829-37.
61. WANG KC, LIM CH, MCMILLEN IC, et al. :Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy. Metabolism 2013;62:1662-72.
62. YAMAMOTO K, OHKI R, LEE RT, et al. :Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 2001;104:1670-5.
63. LUCAS A, MIALET-PEREZ J, DAVIAUD D, et al. :Gadd45gamma regulates cardiomyocyte death and post-myocardial infarction left ventricular remodelling. Cardiovasc Res 2015;108:254-67.
64. DODIC M, MCALINDEN AT, JEFFERIES AJ, et al. :Differential effects of prenatal exposure to dexamethasone or cortisol on circulatory control mechanisms mediated by angiotensin II in the central nervous system of adult sheep. J Physiol 2006;571:651-60.
65. MZAYEK F, SHERWIN R, FONSECA V, et al. :Differential association of birth weight with cardiovascular risk variables in African-Americans and Whites: the Bogalusa heart study. Ann Epidemiol 2004;14:258-64.
66. GABORY A, ATTIG L, JUNIEN C. :Sexual dimorphism in environmental epigenetic programming. Mol Cell Endocrinol 2009;304:8-18.
67. TAKAHASHI T, SAITO M, SCHMIDT AF, et al. :Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy. Am J Obstet Gynecol 2020;223:921.e1-21.e10.
68. SCHMIDT AF, JOBE AH, KANNAN PS, et al. :Oral antenatal corticosteroids evaluated in fetal sheep. Pediatr Res 2019;86:589-94.